About the Regulatory Intelligence category
|
|
0
|
162
|
August 3, 2023
|
Regulatory Differences between EMA and FDA on Nitrosamines
|
|
0
|
171
|
March 6, 2024
|
Entidades regulatorias y su postura en el análisis de nitrosaminas en estudios de estabilidad de preparados farmacéuticos
|
|
0
|
149
|
February 28, 2024
|
Adoption of CPCA beyond FDA/ EMA
|
|
9
|
821
|
January 31, 2024
|
Would we expect new regulations evolution for "PFAS" similar to what the industry had for Nitrosamines since 2018?
|
|
1
|
296
|
December 19, 2023
|
Risk for dossier submission link to secondary amine present on API related impurity
|
|
0
|
254
|
December 8, 2023
|